We spoke with Coby Hanoch, CEO of RERAM IP company Weebit Nano (ASX:WBT), about the license deal Weebit Nano just
On 1 October 2024, Island Pharmaceuticals (ASX:ILA) Executive Chairman Dr. Paul MacLeman spoke at the Pitt Street Research Life Sciences
We spoke with Nigel Broomham, CEO of Battery Age Minerals (ASX: BM8), about the company's recent analysis of a government
On 26 September 2024 we spoke with John de Vries, CEO of Black Rock Mining (ASX: BKT), about the debt
On 29 October 2024, BluGlass CEO Jim Haden talked us through the CLAWS hub, part of the US CHIPS Act,
On 25 July 2023 we spoke with BluGlass CEO Jim Haden and NED Jean-Michel Pelaprat, both laser industry veterans, about
On 27 February 2023, we caught up with BluGlass’ (ASX:BLG) President and CEO, Jim Haden, to talk about BLG’s first
14 May 2025: We spoke with John Kelly, CEO of Atomo Diagnostics (ASX: AT1) about the company's progress with its
On 27 August 2025 we spoke to John Kelly, CEO of Atomo Diagnostics (ASX:AT1), about progress the company is making
Sean Hehir, CEO of BrainChip, spoke at the Pitt Street Research Semiconductor Conference 2025 held in Sydney on 7 May
In a recent interview with BrainChip (ASX:BRN) CEO Sean Hehir, we talked about the company's technology roadmap and how Akida
BrainChip (ASX:BRN): Post AGM interview with CEO Sean Hehir (21 May 2024)
On 2 July 2025 we spoke to Zane Yoshida, CEO of the Calmer Co. (ASX: CCO), about the company's progress
Check out our interview with CEO James McBrayer (4 April 2023)
On 13 October 2025 we spoke to Dr Kilian Kelly, CEO of Cynata Therapeutics (ASX:CYP), about the three clinical studies
